首都医科大学学报 ›› 2017, Vol. 38 ›› Issue (5): 650-653.doi: 10.3969/j.issn.1006-7795.2017.05.004

• 皮肤病性病诊疗与研究 • 上一篇    下一篇

HIV-1慢性感染者外周血中CD8+干细胞样记忆型T细胞变化以及对疾病进展的影响

宋冰冰1, 陆小凡2, 翁文佳1, 粟斌2, 张彤2, 高艳青1   

  1. 1. 首都医科大学附属北京佑安医院皮肤性病科, 北京 100069;
    2. 北京市艾滋病研究北京市重点实验室, 北京 100069
  • 收稿日期:2017-05-09 出版日期:2017-09-21 发布日期:2017-10-18
  • 通讯作者: 高艳青 E-mail:gyqing2001bj@sina.com
  • 基金资助:
    北京市科技计划(D141100000314005)。

Dynamic changes of CD8+ stem memory T cells and their effects on disease progression in chronic HIV-1 infection

Song Bingbing1, Lu Xiaofan2, Weng Wenjia1, Su Bin2, Zhang Tong2, Gao Yanqing1   

  1. 1. Department of Dermatology, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China;
    2. Beijing Key Laboratory of AIDS Research, Beijing 100069, China
  • Received:2017-05-09 Online:2017-09-21 Published:2017-10-18
  • Supported by:
    This study was supported by Science and Technology Plan of Beijing (D141100000314005).

摘要: 目的 观察人类免疫缺陷病毒-1(human immunodeficiency virus-1,HIV-1)慢性感染者外周血中CD8+干细胞样记忆型T细胞(CD8+ stem memory T cells,CD8+TSCM)随治疗的动态变化,分析其与疾病进展的关系。方法 观察25例经抗反转录病毒治疗(antiretroviral therapy,ART)的慢性HIV-1感染者(治疗方案为替诺福韦+依非韦伦+拉米夫定)以及36例健康对照者,对样本外周血单个核细胞(peripheral blood mononuclear cells,PBMC)分别用CD3-APCCy7、CD4-FITC、CD8-PerCPCy5、CD45RA-PECy7、CCR7-APC、CD27-PE、CD95-Pacific Blue抗体和CD38-PE、HLA DR-APC抗体进行细胞表面染色并通过流式细胞仪检测CD8+TSCM细胞比例。比较HIV-1慢性感染者和健康者CD8+TSCM细胞比例的差异,并分析其与疾病进展指标(CD4+T细胞计数、HIV病毒载量以及免疫活化指标)的关系。结果 HIV-1慢性感染组的CD8+TSCM细胞比例小于健康对照组;CD8+ TSCM细胞比例与CD4+ T细胞计数呈正相关,与HIV-1病毒载量以及免疫活化指标CD38+ HLA-DR+ CD8+ T细胞呈负相关;随着ART治疗,CD8+TSCM细胞比例在144周后升至健康对照水平。结论 CD8+TSCM在慢性HIV-1感染中发挥一定的保护作用,HIV-1相关特异性CD8+TSCM细胞可能是未来T细胞疫苗设计的靶点。

关键词: 人类免疫缺陷病毒, 干细胞样记忆性T细胞, 疾病进展

Abstract: Objective To study the dynamics of CD8+ stem memory T cells (TSCM) and the impact of CD8+ TSCM cells on disease progression of human immunodeficiency virus-1 (HIV-1) infection. Methods Twenty-five cases with chronic HIV-1 infection receiving antiretroviral therapy (ART) with tenofovir plus efavirenz + lamivudine and 36 healthy controls were enrolled and observed. Peripheral blood mononuclear cells were stained with using CD3-APCCy7, CD4-FITC, CD8-PerCPCy5, CD45RA-PECy7, CCR7-APC, CD27-PE, CD95-Pacific Blue, CD38-PE, HLA DR-APC monoclonal antibodies, then CD8+ TSCM cell percentage were determined by flow cytometry.To compare the difference of CD8+ TSCM cell percentage between HIV-1 chronic infected persons and healthy subjects, and to analyze the relationship between CD8+ TSCM cell percentage and disease progression index (CD4+ T cell count, HIV-1 viral load and immune activation index).Results Chronic HIV-1 infection resulted in a decrease of the CD8+ TSCM cell proportion in HIV-1 patients. CD8+ TSCM cells positively correlated with CD4+ T cell counts and negatively correlated with plasma viral load and CD8+ T cell activation. Prolonged ART successfully recovered the CD8+ TSCM cells, and the dynamic change of CD8+ TSCM cells was in parallel with CD4+ T cell restoration and a decrease in the level of T cell immune activation. Conclusion In summary, this report identifies CD8+ TSCM as a correlate of protection from disease progression. HIV-1-specific CD8 + TSCM can presumably directly contribute to the design of T cell-based vaccines.

Key words: human immunodeficiency virus, stem memory T cells, disease progression

中图分类号: